114 related articles for article (PubMed ID: 8449205)
21. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
Evans MA; Burnett JC; Redfield MM
J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
[TBL] [Abstract][Full Text] [Related]
22. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
[TBL] [Abstract][Full Text] [Related]
23. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
24. Captopril does not prevent nitroglycerin tolerance in heart failure.
Dupuis J; Lalonde G; Bichet D; Rouleau JL
Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
[TBL] [Abstract][Full Text] [Related]
25. Captopril in congestive heart failure resistant to other vasodilators.
Fouad FM; El-Tobgi S; Tarazi RC; Bravo EL; Hart NJ; Shirey EK; Lim J
Eur Heart J; 1984 Jan; 5(1):47-54. PubMed ID: 6368232
[TBL] [Abstract][Full Text] [Related]
26. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy.
Dakak N; Makhoul N; Merdler A; Yechiely H; Kahana L; Halon DA; Schneeweiss A; Lewis BS
Eur Heart J; 1993 Jun; 14(6):836-44. PubMed ID: 8325314
[TBL] [Abstract][Full Text] [Related]
28. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
[TBL] [Abstract][Full Text] [Related]
29. Captopril and spironolactone therapy for refractory congestive heart failure.
Dahlström U; Karlsson E
Am J Cardiol; 1993 Jan; 71(3):29A-33A. PubMed ID: 8422001
[TBL] [Abstract][Full Text] [Related]
30. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
Dzau VJ; Swartz SL
Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460
[TBL] [Abstract][Full Text] [Related]
32. Antidiuretic hormone and atrial natriuretic peptide in congestive heart failure.
Fyhrquist F; Tikkanen I
Acta Med Scand Suppl; 1986; 707():55-8. PubMed ID: 2943143
[TBL] [Abstract][Full Text] [Related]
33. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
Cody RJ; Covit A; Schaer G; Williams G
Am Heart J; 1982 Nov; 104(5 Pt 2):1180-3. PubMed ID: 6291363
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
McAlpine HM; Morton JJ; Leckie B; Dargie HJ
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S25-30. PubMed ID: 2441196
[TBL] [Abstract][Full Text] [Related]
35. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
[TBL] [Abstract][Full Text] [Related]
36. Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition.
Eiskjaer H; Bagger JP; Mogensen CE; Schmitz A; Pedersen EB
Scand J Clin Lab Invest; 1992 May; 52(3):193-9. PubMed ID: 1411251
[TBL] [Abstract][Full Text] [Related]
37. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
Sharpe DN; Coxon RJ
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
[TBL] [Abstract][Full Text] [Related]
38. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
39. Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure.
Tarazi RC; Fouad FM; Ceimo JK; Bravo EL
Am J Cardiol; 1979 Oct; 44(5):1013-8. PubMed ID: 115305
[No Abstract] [Full Text] [Related]
40. Atrial natriuretic peptide in congestive heart failure: postural changes and reset with chronic captopril therapy.
Rouleau JL; Bichet D; Kortas C
Am Heart J; 1988 May; 115(5):1060-7. PubMed ID: 2966547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
